News | January 12, 2023
H.B. Fuller to launch new bio-compatible adhesive for medical applications
Swiftmelt 1515-I meets performance requirements and secures skin attachment
Swiftmelt 1515-I meets performance requirements and secures skin attachment
Advanz Pharma will leverage its specialty, hospital, and rare disease expertise and infrastructure to commercialize AT-007 in Europe for both Galactosemia and SORD Deficiency
If approved, the vaccine could help simplify the meningococcal vaccination schedule and provide the broadest serogroup coverage of any meningococcal vaccine
MindRank expects to initiate a Phase I safety study in the first quarter of 2023.
Proceeds from the transaction will be reinvested towards the growth, innovation and expansion of Healthium’s advanced surgery, orthopaedics, wound care and post-surgical care portfolio
Application includes data from key phase III trials, including the pivotal MOMENTUM trial, which met all primary and key secondary efficacy endpoints
PIKA COVID-19 vaccine is currently in Phase 3, multi-country, multi-center clinical trial conducted at Southeast Asian and Middle East countries.
Pantoprazole Sodium Sesquihydrate are proton pump inhibitors used in drugs to suppress the gastric acid secretion
The CRL did not identify any outstanding scientific issues with the product.
Subscribe To Our Newsletter & Stay Updated
